4-Amino-5-Fluoro-3-[6-(4-Methylpiperazin-1-YL)-1H-Benzimidazol-2-YL]-1H-Quinolin-2-one for use in the Treatment of Adenoid Cystic Carcinoma
US-2015182525-A1 · Jul 2, 2015 · US
Wick Michael holds 1 patent in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 1 |
| Recent patents | 0 |
| First publication | Jul 2, 2015 |
| Latest publication | Jul 2, 2015 |
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2015 | 1 |
| Year | Patents |
|---|---|
| 2015 | 1 |
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/337 | 1 |
| A61K31/496 | 1 |
| A61K31/4709 | 1 |
| A61P35/00 | 1 |
| C07D401/14 | 1 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1 |
| Chemistry & Metallurgy | 1 |